RxDoctor Payments Data

Juan Camilo Mora Herrera, MD

Pain Medicine · Gainesville, FLNPI 1194168641

Payments from drug & device makers

What this record shows

10 manufacturers reported payments, led by Relievant Medsystems, Inc. at 30.5% of the total. Reporting peaked in 2022 at $2,980 and has fallen 89.5% since, to $313 in 2025.

$5,440in general payments, 2019–2025

Across 41 payments — averaging $132.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Relievant Medsystems, Inc.$2K
  • Abbott$1K
  • Stimwave Technologies Incorporated$948
  • SPR Therapeutics, Inc$803
  • Boston Scientific$431
  • Stryker$172
  • plus $362 from 4 others
$38,543in research payments, 2019–2025

Across 38 payments — averaging $1014.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$39K

What the payments were for

  • Travel & lodging$2,94554%
  • Food & beverage$2,49446%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,440 in reported general payments places this provider in the 65th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$103,070
Medicare patients
294
Services billed
1,137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin143$3,171
Duloxetine Hcl146$2,899
Gabapentin110$1,702
Topiramate55$903
Venlafaxine Hcl ErVenlafaxine Hcl37$804
Tramadol Hcl39$534
Celecoxib11$419
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$87
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$45

Paid to pharmacies, not to this prescriber.

Other pain medicine in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →